BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23216354)

  • 21. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
    Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AGC1 deficiency and cerebral hypomyelination.
    Wolf NI; van der Knaap MS
    N Engl J Med; 2009 Nov; 361(20):1997-8; author reply 1998. PubMed ID: 19907050
    [No Abstract]   [Full Text] [Related]  

  • 23. Reduced N-acetylaspartate levels in mice lacking aralar, a brain- and muscle-type mitochondrial aspartate-glutamate carrier.
    Jalil MA; Begum L; Contreras L; Pardo B; Iijima M; Li MX; Ramos M; Marmol P; Horiuchi M; Shimotsu K; Nakagawa S; Okubo A; Sameshima M; Isashiki Y; Del Arco A; Kobayashi K; Satrústegui J; Saheki T
    J Biol Chem; 2005 Sep; 280(35):31333-9. PubMed ID: 15987682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium-regulation of mitochondrial respiration maintains ATP homeostasis and requires ARALAR/AGC1-malate aspartate shuttle in intact cortical neurons.
    Llorente-Folch I; Rueda CB; Amigo I; del Arco A; Saheki T; Pardo B; Satrústegui J
    J Neurosci; 2013 Aug; 33(35):13957-71, 13971a. PubMed ID: 23986233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutamate excitotoxicity and Ca2+-regulation of respiration: Role of the Ca2+ activated mitochondrial transporters (CaMCs).
    Rueda CB; Llorente-Folch I; Traba J; Amigo I; Gonzalez-Sanchez P; Contreras L; Juaristi I; Martinez-Valero P; Pardo B; Del Arco A; Satrustegui J
    Biochim Biophys Acta; 2016 Aug; 1857(8):1158-1166. PubMed ID: 27060251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The nigrostriatal dopamine system of aging GFRalpha-1 heterozygous mice: neurochemistry, morphology and behavior.
    Zaman V; Boger HA; Granholm AC; Rohrer B; Moore A; Buhusi M; Gerhardt GA; Hoffer BJ; Middaugh LD
    Eur J Neurosci; 2008 Oct; 28(8):1557-68. PubMed ID: 18973577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered postnatal development of cortico-hippocampal neuronal electric activity in mice deficient for the mitochondrial aspartate-glutamate transporter.
    Gómez-Galán M; Makarova J; Llorente-Folch I; Saheki T; Pardo B; Satrústegui J; Herreras O
    J Cereb Blood Flow Metab; 2012 Feb; 32(2):306-17. PubMed ID: 21934695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficiency of Mitochondrial Aspartate-Glutamate Carrier 1 Leads to Oligodendrocyte Precursor Cell Proliferation Defects Both In Vitro and In Vivo.
    Petralla S; Peña-Altamira LE; Poeta E; Massenzio F; Virgili M; Barile SN; Sbano L; Profilo E; Corricelli M; Danese A; Giorgi C; Ostan R; Capri M; Pinton P; Palmieri F; Lasorsa FM; Monti B
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
    Lin Z; Dodd CA; Filipov NM
    Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The control of brain mitochondrial energization by cytosolic calcium: the mitochondrial gas pedal.
    Gellerich FN; Gizatullina Z; Gainutdinov T; Muth K; Seppet E; Orynbayeva Z; Vielhaber S
    IUBMB Life; 2013 Mar; 65(3):180-90. PubMed ID: 23401251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic development of prenatal ventral mesencephalon and striatum in organotypic co-cultures.
    Lyng GD; Snyder-Keller A; Seegal RF
    Brain Res; 2007 Feb; 1133(1):1-9. PubMed ID: 17196555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aralar mRNA and protein levels in neurons and astrocytes freshly isolated from young and adult mouse brain and in maturing cultured astrocytes.
    Li B; Hertz L; Peng L
    Neurochem Int; 2012 Dec; 61(8):1325-32. PubMed ID: 23017600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-prevalence mosaicism of chromosome 18q distal deletion identified by exome-based copy number profiling in a child with cerebral hypomyelination.
    Shiohama T; Nakashima M; Ikehara H; Kato M; Saitsu H
    Congenit Anom (Kyoto); 2020 May; 60(3):94-96. PubMed ID: 31328296
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson's disease motor symptoms without neuronal degeneration in adult mice.
    Isingrini E; Guinaudie C; C Perret L; Rainer Q; Moquin L; Gratton A; Giros B
    Sci Rep; 2017 Sep; 7(1):12432. PubMed ID: 28963508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prooxidant properties of ascorbic acid in the nigrostriatal dopaminergic system of C57BL/6 mice.
    Kang MJ; Lee SS; Koh HC
    Toxicology; 2012 Mar; 294(1):1-8. PubMed ID: 22285708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citrin deficiency: Does the reactivation of liver aralar-1 come into play and promote HCC development?
    Mention K; Joncquel Chevalier Curt M; Dessein AF; Douillard C; Dobbelaere D; Vamecq J
    Biochimie; 2021 Nov; 190():20-23. PubMed ID: 34228977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pael receptor is involved in dopamine metabolism in the nigrostriatal system.
    Imai Y; Inoue H; Kataoka A; Hua-Qin W; Masuda M; Ikeda T; Tsukita K; Soda M; Kodama T; Fuwa T; Honda Y; Kaneko S; Matsumoto S; Wakamatsu K; Ito S; Miura M; Aosaki T; Itohara S; Takahashi R
    Neurosci Res; 2007 Dec; 59(4):413-25. PubMed ID: 17889953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uncoupling protein-2 promotes nigrostriatal dopamine neuronal function.
    Andrews ZB; Rivera A; Elsworth JD; Roth RH; Agnati L; Gago B; Abizaid A; Schwartz M; Fuxe K; Horvath TL
    Eur J Neurosci; 2006 Jul; 24(1):32-6. PubMed ID: 16882005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease.
    Divito CB; Steece-Collier K; Case DT; Williams SP; Stancati JA; Zhi L; Rubio ME; Sortwell CE; Collier TJ; Sulzer D; Edwards RH; Zhang H; Seal RP
    J Neurosci; 2015 Nov; 35(45):14983-99. PubMed ID: 26558771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.